Literature DB >> 17578789

Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women.

Judith S Currier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578789     DOI: 10.1086/518977

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

1.  Zidovudine and Lamivudine for HIV Infection.

Authors:  Peter L Anderson; Joseph E Rower
Journal:  Clin Med Rev Ther       Date:  2010

2.  Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy.

Authors:  Daniel J Westreich; Ian Sanne; Mhairi Maskew; Babatyi Malope-Kgokong; Francesca Conradie; Pappie Majuba; Michele Jonsson Funk; Jay S Kaufman; Annelies Van Rie; Patrick Macphail
Journal:  Clin Infect Dis       Date:  2009-06-01       Impact factor: 9.079

3.  Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa.

Authors:  Vivian Black; Risa M Hoffman; Catherine A Sugar; Priya Menon; Francois Venter; Judith S Currier; Helen Rees
Journal:  J Acquir Immune Defic Syndr       Date:  2008-11-01       Impact factor: 3.731

Review 4.  Acute pancreatitis in HIV/AIDS patients: an issue of concern.

Authors:  Gordana Dragovic
Journal:  Asian Pac J Trop Biomed       Date:  2013-06

5.  NRTI backbone in HIV treatment: will it remain relevant?

Authors:  Randall Tressler; Catherine Godfrey
Journal:  Drugs       Date:  2012-11-12       Impact factor: 9.546

Review 6.  Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?

Authors:  N Kumarasamy; Atul Patel; Sanjay Pujari
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

Review 7.  The Importance of Gender-Related Anticancer Research on Mitochondrial Regulator Sodium Dichloroacetate in Preclinical Studies In Vivo.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Eligija Damanskienė; Angelija Valančiūtė; Ingrida Balnytė; Marta Maria Alonso
Journal:  Cancers (Basel)       Date:  2019-08-20       Impact factor: 6.639

8.  Determinants of viral load rebound on HIV/AIDS patients receiving antiretroviral therapy: results from South Africa.

Authors:  Claris Shoko; Delson Chikobvu
Journal:  Theor Biol Med Model       Date:  2018-07-16       Impact factor: 2.432

9.  Plasma cytokine profiles in HIV-1 infected patients developing neuropathic symptoms shortly after commencing antiretroviral therapy: a case-control study.

Authors:  Johan J Van der Watt; Katalin A Wilkinson; Robert J Wilkinson; Jeannine M Heckmann
Journal:  BMC Infect Dis       Date:  2014-02-10       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.